UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

PloS one, 2018-12, Vol.13 (12), p.e0208936-e0208936

2018

Volltextzugriff (PDF)

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

Journal of clinical oncology, 2005-10, Vol.23 (29), p.7312-7321

2005

Volltextzugriff (PDF)

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

Journal of clinical oncology, 2011-02, Vol.29 (6), p.698-703

2011

Volltextzugriff (PDF)

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Experimental cell research, 2013-03, Vol.319 (5), p.612-622

2013

Volltextzugriff (PDF)

Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk

Stem cell reports, 2014-07, Vol.3 (1), p.24-33

2014

Volltextzugriff (PDF)

Treatment With Nephrectomy Only for Small, Stage I/Favorable Histology Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3719-3724

2001

Volltextzugriff (PDF)

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

The Journal of clinical investigation, 2011-01, Vol.121 (1), p.174-183

2011

Volltextzugriff (PDF)

Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1

The Journal of pediatrics, 1993-11, Vol.123 (5), p.673-678

1993

Volltextzugriff (PDF)

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

Pediatric blood & cancer, 2008-02, Vol.50 (2), p.236-241

2008

Volltextzugriff (PDF)

Monitoring Therapy with MEK Inhibitor U0126 in a Novel Wilms Tumor Model in Wt1 Knockout Igf2 Transgenic Mice Using 18F-FDG PET with Dual-Contrast Enhanced CT and MRI: Early Metabolic Response Without Inhibition of Tumor Growth

Molecular imaging and biology, 2013-04, Vol.15 (2), p.175-185

2013

Volltextzugriff (PDF)

Characterization of a Wilms tumor in a 9‐year‐old girl with trisomy 18

American journal of medical genetics. Part A, 2003-08, Vol.121A (1), p.52-55

2003

Volltextzugriff (PDF)

Pulmonary dysplasia, Denys-Drash syndrome and wilms tumor 1 gene mutation in twins

Pediatric nephrology (Berlin, West), 2001-03, Vol.16 (3), p.227-231

2001

Volltextzugriff (PDF)

Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis

Pediatric and developmental pathology, 2000-11, Vol.3 (6), p.561-567

2000

Volltextzugriff (PDF)

RNA Expression of the WT1 Gene in Wilms' Tumors in Relation to Histology

JNCI : Journal of the National Cancer Institute, 1992-02, Vol.84 (3), p.181-187

1992

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNeoplasia

SpracheEnglisch

ThemaWilms Tumor - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk

Treatment With Nephrectomy Only for Small, Stage I/Favorable Histology Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q

Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

Monitoring Therapy with MEK Inhibitor U0126 in a Novel Wilms Tumor Model in Wt1 Knockout Igf2 Transgenic Mice Using 18F-FDG PET with Dual-Contrast Enhanced CT and MRI: Early Metabolic Response Without Inhibition of Tumor Growth

Characterization of a Wilms tumor in a 9‐year‐old girl with trisomy 18

Pulmonary dysplasia, Denys-Drash syndrome and wilms tumor 1 gene mutation in twins

Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis

RNA Expression of the WT1 Gene in Wilms' Tumors in Relation to Histology

Aktive Filter

Suchergebnisse filtern